Clinical Trials Browser

Phase 1/2 × ProMune × Dermatologic × Clear all

NCT00145158 2022-10-10

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Phase 1/2 Terminated

23 enrolled 8 charts

Melanoma

NCT00145145 2022-10-07

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Phase 1/2 Terminated

1 enrolled 4 charts

Melanoma

NCT00043420 2009-02-12

CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Phase 1/2 Completed

DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous